Document is current
Any future updates will be listed below
-
Authors
Tsesmelis, Miltiadis
Büttner, Ulrike F. G.
Gerstenlauer, Melanie
Manfras, Uta
Tsesmelis, Konstantinos
Du, Ziwei
Sperb, Nadine
Weissinger, Stephanie Ellen
Möller, Peter
Barth, Thomas F. E.
Maier, Harald J.
Chan, Lap Kwan
Wirth, Thomas
-
Funding
Funding for this research was provided by:
Universität Ulm
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 31 March 2024
First Online: 16 May 2024
Change Date: 12 September 2024
Change Type: Update
Change Details: The Additional files 2 and 3 were requested by the author to be added back in the article. These were found in the proofs but have been removed in the published version.
Declarations
:
: Patient consent was obtained and adhered to the declaration of Helsinki, regulations of German and Swiss legislation and publicly available data of TCGA for the survival analysis of patients from University Hospital Ulm and Human Protein Atlas (HPA), respectively. The study was performed according to ARRIVE guidelines and the German animal welfare legislation and approved by the responsible government agency. The maximal tumor size/burden permitted by the ethics committee was 1cm. In case tumor reached that size, the mouse was euthanized and added to the HEP group.
: Not applicable.
: The authors declare no competing interests.
